Found 5 matching trials
The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 PHASE3 A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Inves...
Show More Location
Laboratory for Muscle Diseases and Neuropathies
Learn More & Join Trial
Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2 PHASE3 A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Inves...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR PHASE3 An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and...
Show More Location
Universitair Ziekenhuis Leuven"UZ Leuven Gasthuisberg Campus Herestraat 49 Leuven, 3000"
Learn More & Join Trial
An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study. PHASE3 This is an open-label extension study intended to evaluate the long-term sa...
Show More Status
Enrolling By Invitation
Location
Laboratory for Muscle Diseases and Neuropathies
Learn More & Join Trial
Treatment of Myotonia - Lamotrigine Versus Namuscla NA In this clinical study, the aim is to investigate whether there is a differ...
Show More Location
Copenhagen Neuromuscular Center, department of Neurology, Rigshospitalet
Learn More & Join Trial